Why Do Cancer Patients Use IV Immunoglobulins?
IV Immunoglobulins (IVIG) are purified antibodies administered through an intravenous infusion. For cancer patients, especially those with hematologic malignancies or undergoing chemotherapy, IVIG is used as an immune support therapy to reduce infections, stabilize immune response, and improve resilience.
Who May Benefit from IVIG in Cancer Care?
- Patients with low immunoglobulin levels (hypogammaglobulinemia)
- Those undergoing intensive chemotherapy or stem cell transplant
- Patients with frequent infections (pneumonia, sepsis, chronic sinusitis)
- Individuals with certain lymphomas, leukemias, or multiple myeloma
What Are the Benefits?
Reduce frequency and severity of infections
Stabilize immune response in immune-suppressed patients
Support quality of life and treatment tolerance
Improve recovery after chemotherapy
Is It Safe?
IVIG is generally well tolerated when given under proper medical supervision. Side effects are uncommon but may include mild flu-like symptoms or infusion reactions. It’s important for the healthcare team to monitor dosage, infusion rate, and patient history.
Always discuss with your oncologist or palliative care team to determine whether IVIG is appropriate for your care plan.
結語：對於免疫力低下或常見感染的癌症病人而言，IVIG 是一項重要的支持性療法。它雖不是抗癌藥物，但可在病人最脆弱的時期，提供實質的保護與提升康復能力。
Medical Disclaimer:
The information provided in this article is for educational and reference purposes only and does not constitute medical advice or be used as a substitute for professional medical diagnosis, treatment, or advice. ALWAYS CONSULT ANY QUESTIONS YOU MAY HAVE ABOUT YOUR MEDICAL CONDITION OR MEDICAL PROBLEM THAT YOU HAVE ALWAYS CONSULT YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROFESSIONAL. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be construed as such. If you develop symptoms or require medical assistance, please contact a healthcare professional promptly.